The Lymphoma Academic Research Organisation

This study tested a four-drug combination including pixantrone for adults with aggressive non-Hodgkin lymphoma that had returned or not responded to previous treatments. The main goal was to see if the treatment could shrink or eliminate the cancer, as measured by PET scans. Rese…

This study tested a multi-step treatment approach for adults with previously untreated mantle cell lymphoma, a type of blood cancer. Patients received chemotherapy combined with a targeted drug (obinutuzumab), followed by a stem cell transplant using their own cells. After the tr…

This large study tested whether combining two drugs (lenalidomide and rituximab) works better than standard chemotherapy plus rituximab for people with previously untreated follicular lymphoma, a type of blood cancer. Researchers enrolled over 1,000 patients to see which combinat…

This study tested an experimental drug called glofitamab for patients with aggressive lymphomas whose cancer returned or didn't respond after CAR-T cell therapy. The trial enrolled 67 patients across two groups with different lymphoma types. Researchers aimed to see if this new a…